Pierre van der Bruggen lab

We try to understand why tumor-infiltrating lymphocytes are unable to kill tumor cells, and to find strategies to overcome this blockage. We have discovered that the anergy of human tumor-infiltrating lymphocytes can be due to the presence of galectin-3, a lectin abundant in tumors.